Nutracryst Therapeutics Private Limited - Company Profile

It is a pharma private limited company based in New Delhi, Delhi, India, established in 2004.
2004 New Delhi, Delhi, India Active
Last Updated:
Access Report
About Nutracryst Therapeutics Private Limited

Nutracryst Therapeutics Private Limited, a active private limited company, was established on 13 September 2004 in New Delhi, Delhi, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24233DL2004PTC129013. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.

Formerly known as M J J Exim Private Limited. It upholds a active non-compliant status. Its leadership includes Anil Sapra (Director), Rajnish Garg (Director). Past directors included Anil Sapra, Rajnish Garg. It holds ₹1.99 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2017, with the balance sheet filed on 31 March 2017. It is based at 60, Dayanand Marg , Daryaganj,, New Delhi, Delhi, 110002.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24233DL2004PTC129013

  • Registration Number

    129013

  • Incorporation Date

    13 September 2004

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 21 Year, 5 Months
  • Last Filing with ROC 31 Mar 2017
  • Open Charges ₹ 1.99 Cr
  • Revenue Growth **** %
  • Profit Growth **** 3.44%
  • Ebitda **** -89.57%
  • Net Worth -49.87%
  • Total Assets -2.24%
Company report

Nutracryst Therapeutics Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Nutracryst Therapeutics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Nutracryst Therapeutics Private Limited?
Current Directors
Name Designation Appointment Date Status
Anil Sapra Director 15 Jun 2005 Current
Rajnish Garg Director 15 Jun 2005 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 27 Nov 2018 Past
Pramod Abcsdd Director 13 Dec 2018 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Nutracryst Therapeutics.

Nutracryst Therapeutics Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a slight improvement in profitability, with a 3.44% increase in profit. The company's net worth observed a substantial decline by a decrease of 49.87%.

Nutracryst Therapeutics revenue growth over time
Nutracryst Therapeutics profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
 -2.24%
*******
*******
*******
*******
Profit or Loss
*******
 3.44%
*******
*******
*******
*******
Net Worth
*******
 -49.87%
*******
*******
*******
*******
EBITDA
*******
 -89.57%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Nutracryst Therapeutics?

In 2017, Nutracryst Therapeutics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹19,860,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Canara Bank : 1.99 Cr
Latest Charge Details
Date Lender Amount Status
22 Aug 2005 Canara Bank ₹1.99 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Nutracryst Therapeutics?

Unlock and access historical data on people associated with Nutracryst Therapeutics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Nutracryst Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nutracryst Therapeutics's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Nutracryst Therapeutics
Recent Activity within the Organization
  • Annual General Meeting

    Nutracryst Therapeutics Private Limited last Annual general meeting of members was held on 30 Sep 2017 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Nutracryst Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2017 with Roc Delhi. was recorded as a recent event.

  • Charges

    The activity A charge with Canara Bank amounted to Rs. 19.86 M with Charge ID 90368090 was registered on 22 Aug 2005. was completed.

  • Director Appointment

    Anil Sapra was appointed as a Director was appointed as a Director on 15 Jun 2005 & has been associated with this company since 20 years 8 months . was recorded as a recent event.

  • Director Appointment

    Rajnish Garg was appointed as a Director was appointed as a Director on 15 Jun 2005 & has been associated with this company since 20 years 8 months . was recorded as a recent event.

  • Company Incorporation

    Nutracryst Therapeutics Private Limited was registered on 13 Sep 2004 with Roc Delhi & aged 21 years 5 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Nutracryst Therapeutics Private Limited?

The CIN of Nutracryst Therapeutics Private Limited is U24233DL2004PTC129013.

Where is Nutracryst Therapeutics Private Limited headquartered?

Nutracryst Therapeutics Private Limited is headquartered at 60, Dayanand Marg , Daryaganj,, New Delhi, Delhi, 110002.

When was Nutracryst Therapeutics Private Limited incorporated?

Nutracryst Therapeutics Private Limited was incorporated on 13 September 2004.

Who are the current directors of Nutracryst Therapeutics Private Limited?

The current directors of Nutracryst Therapeutics Private Limited are

What is the primary industry of Nutracryst Therapeutics Private Limited?

The primary industry of Nutracryst Therapeutics Private Limited is Pharma.

Is Nutracryst Therapeutics Private Limited a listed company?

Nutracryst Therapeutics Private Limited is unlisted.

What is the capital structure of Nutracryst Therapeutics Private Limited?

The authorized capital of Nutracryst Therapeutics Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Nutracryst Therapeutics Private Limited?

The compliance status of Nutracryst Therapeutics Private Limited is Active Non-Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available